What are the latest funding news in the alternative protein market? (July 2026)
Download our beautiful pitch about the alternative protein market
In our alternative protein market deck, you will find everything you need to understand the market
Alternative protein funding in July 2026 looked more selective than broad, with investors backing companies that can improve cost, texture, scale, and manufacturing efficiency.
The most recent deals were concentrated in fermentation, mycelium, animal-free dairy proteins, cultivated chicken, and whole-cut meat or seafood alternatives.
The 12 latest disclosed rounds represented about $138M in funding, with Europe and North America leading most of the visible activity.
And if you want to better understand this new industry, you can download our pitch covering the alternative protein market.
Insights
- Fermentation-related models dominated the latest alternative protein funding, appearing in most of the 12 deals through precision fermentation, mycelium, mycoprotein, or fermentation infrastructure.
- Animal-free dairy proteins remained one of the strongest pockets, with Standing Ovation, Those Vegan Cowboys, AuX Labs, and Cosaic all raising for casein or dairy functionality.
- Scale-up capital mattered more than discovery capital, as many companies raised to build manufacturing capacity, move toward launch, or support commercial partnerships.
- Europe was the clearest regional hub, with Germany, Denmark, the UK, Switzerland, France, Israel, and the Dutch-Belgian ecosystem all represented in recent deals.
- Mycelium moved from niche foodtech into serious manufacturing discussions, with Pacifico Biolabs, Adamo Foods, and Tempty Foods all raising for meat alternative scale-up.
- Whole-cut products stayed important because investors backed technologies that improve texture in steaks, fillets, seafood, and chicken alternatives, not only minced or processed formats.
- Alternative seafood remained smaller but active, with Oshi raising strategic capital for a US retail push and NS/TX covering seafood analogues through its manufacturing platform.
- Several rounds blended equity, grants, credit, or crowdfunding, showing that alternative protein startups increasingly use mixed financing to survive capital-intensive scale-up.
As this chart shows, and as featured in our alternative protein market deck, search interest in pea protein has been growing steadily
Summary table of the latest funding deals in the alternative protein market as of July 2026
We define the alternative protein market as all modern technologies that provide protein for human food as a substitute for conventional meat, seafood, dairy, and eggs.
We include plant-based meat, seafood, dairy and egg products, fermentation-derived proteins used in such foods, and cultivated cell-based meat and seafood.
We exclude generic plant staples like beans, lentils, tofu and wheat gluten sold as ordinary foods, as well as insect, algae and other novel proteins, unless they are clearly positioned as meat, seafood, dairy or egg alternatives.
You can also read our detailed analysis to understand how funding activity in the alternative protein market has evolved over the last few years.
We also have a quarter-by-quarter analysis of funding activity in the market here.
Finally, you can check our complete list of fundraising deals for the alternative protein market we update this list every quarter as well as our ranking of the most funded startups.
| Name | When | Amount in $ | Round Type | Category |
|---|---|---|---|---|
| NS/TX Industries | 12 June 2026 | $10.5M | Series A + grants | Plant-based whole-cut meat & seafood manufacturing |
| Pacifico Biolabs | 27 May 2026 | ~$8.0M | Series A | Mycelium meat alternative |
| Oshi | 26 May 2026 | $3.0M | Strategic investment + community round | Plant-based seafood |
| StrainX Bioworks | 25 May 2026 | $13.0M | Series A | Precision fermentation ingredients |
| SuperMeat | 13 May 2026 | $6.0M | Series A-4 first close | Cultivated chicken |
| Adamo Foods | 12 May 2026 | ~$10.8M | EU grant | Mycelium whole-cut meat |
| Tempty Foods | 8 May 2026 | ~$0.48M | Equity crowdfunding | Mycelium meat alternative |
| AuX Labs | 22 April 2026 | $4.0M | Seed | Precision-fermented casein |
| Cosaic | 21 April 2026 | $6.0M | Seed extension | Yeast-derived dairy alternative ingredient |
| Planetary | 20 April 2026 | $28.0M | Series A + credit | Fermentation infrastructure & mycoprotein platform |
| Standing Ovation | 31 March 2026 | ~$34.2M | Series B + non-dilutive financing | Precision-fermented casein |
| Those Vegan Cowboys | 6 March 2026 | ~$14.2M | Equity funding + crowdfunding | Precision-fermented casein |
All the latest funding deals during in the alternative protein market as of July 2026
NS/TX Industries raised $10.5M in June 2026
When was it?
The deal was announced on 12 June 2026.
Who are they?
NS/TX Industries builds automated manufacturing technology for whole-cut plant-based steaks, fillets, burgers, red-meat analogues, and seafood analogues.
Geographical focus?
NS/TX Industries is based in Toronto and is building Canadian production capacity while working toward global brand partnerships.
Why do we include them in the alternative protein market?
NS/TX Industries belongs in the alternative protein market as a plant-based whole-cut meat and seafood manufacturing platform.
What is the company stage?
NS/TX Industries is in commercial scale-up after launching its first commercial line and preparing a higher-capacity automated V2 line.
How much did they raise?
NS/TX Industries raised $10.5M, including Series A equity and non-dilutive grant funding.
What round is it?
The round was a Series A combined with non-dilutive grants.
Why did they raise?
NS/TX Industries raised to automate whole-cut alternative protein manufacturing, expand capacity, and make its process available to food brands.
Pacifico Biolabs raised about $8M in May 2026
When was it?
The deal was announced on 27 May 2026.
Who are they?
Pacifico Biolabs grows mycelium-based chicken alternatives in brewery tanks, turning underused brewing infrastructure into protein production capacity.
Geographical focus?
Pacifico Biolabs is based in Germany and is initially focused on DACH and Nordic Europe.
Why do we include them in the alternative protein market?
Pacifico Biolabs belongs in the alternative protein market because its core product is a mycelium meat alternative for human food.
What is the company stage?
Pacifico Biolabs is in early commercialization and scale-up, with commercial launches planned across DACH and Nordic Europe.
How much did they raise?
Pacifico Biolabs raised €7M, equal to about $8M.
What round is it?
The round was a Series A.
Why did they raise?
Pacifico Biolabs raised to scale production, use idle brewery tanks, and launch lower-cost mycelium chicken alternatives.
This chart, featured in our alternative protein market deck, compares the main business model options for alternative protein brands
Oshi raised $3M in May 2026
When was it?
The deal was reported in May 2026, with media coverage on 21 May and tracker dating on 26 May.
Who are they?
Oshi makes whole-cut plant-based seafood, including salmon and whitefish fillets designed to cook, flake, and taste like fish.
Geographical focus?
Oshi is focused on US retail and foodservice expansion, with strategic support from Latin America’s seafood industry.
Why do we include them in the alternative protein market?
Oshi belongs in the alternative protein market because it is a plant-based seafood replacement company.
What is the company stage?
Oshi is in growth stage, with restaurant traction, a whitefish launch, and a planned 686-door US retail rollout.
How much did they raise?
Oshi raised $3.0M.
What round is it?
The round was a strategic investment combined with a public community round.
Why did they raise?
Oshi raised to support a national US retail expansion and launch Oshi Whitefish alongside its plant-based salmon.
StrainX Bioworks raised $13M in May 2026
When was it?
The deal was announced on 25 May 2026.
Who are they?
StrainX Bioworks uses precision fermentation to make food and nutritional ingredients, including alternative proteins and flavor ingredients.
Geographical focus?
StrainX Bioworks is based in India and is positioning the country as a fermentation manufacturing hub for global markets.
Why do we include them in the alternative protein market?
StrainX Bioworks belongs in the alternative protein market because its core technology makes fermentation-derived food proteins and ingredients.
What is the company stage?
StrainX Bioworks is moving from early commercialization into scale-up, with a 10,000-litre facility and larger capacity plans.
How much did they raise?
StrainX Bioworks raised $13.0M.
What round is it?
The round was a Series A.
Why did they raise?
StrainX Bioworks raised to scale manufacturing, expand R&D, and accelerate commercialization of precision-fermented food and nutritional ingredients.
This chart, featured in our alternative protein market deck, looks at Impossible Foods’ strategy in alternative protein
SuperMeat raised $6M in May 2026
When was it?
The deal was announced on 13 May 2026.
Who are they?
SuperMeat grows real chicken meat directly from animal cells using a continuous cultivated-meat production process.
Geographical focus?
SuperMeat is based in Israel and is targeting Switzerland as its first commercial launch market.
Why do we include them in the alternative protein market?
SuperMeat belongs in the alternative protein market as a cultivated chicken company.
What is the company stage?
SuperMeat is in regulatory and commercial launch preparation, with a Swiss filing and licensing-led commercialization strategy.
How much did they raise?
SuperMeat raised $6.0M as the first close of a targeted $10M round.
What round is it?
The round was a Series A-4 first close.
Why did they raise?
SuperMeat raised to support Swiss market entry, regulatory approval, scale-up, and licensing-based commercialization.
Adamo Foods secured about $10.8M in May 2026
When was it?
The deal was announced on 12 May 2026.
Who are they?
Adamo Foods makes whole-cut mycelium-based meat alternatives, including steak-style products designed to compete with conventional beef.
Geographical focus?
Adamo Foods is based in the UK and is targeting UK foodservice first, with European project partners supporting scale-up.
Why do we include them in the alternative protein market?
Adamo Foods belongs in the alternative protein market because it makes whole-cut meat substitutes from mycelium.
What is the company stage?
Adamo Foods is in pilot-to-industrial scale-up through a three-year industrialization project.
How much did they raise?
Adamo Foods secured €10M, equal to about $10.8M, in EU-backed non-dilutive funding.
What round is it?
The round was non-dilutive EU grant funding through the CBE JU-backed MycoStruct project.
Why did they raise?
Adamo Foods raised to industrialize mycelium steak production, use food industry sidestreams, and move toward price-competitive whole-cut meat alternatives.
In our alternative protein market deck, we identify pain points entrepreneurs should prioritize
Tempty Foods raised about $0.48M in May 2026
When was it?
The campaign passed its target on 8 May 2026 and later completed in June 2026.
Who are they?
Tempty Foods makes clean-label mycelium-based meat alternatives for meals, retail, and foodservice.
Geographical focus?
Tempty Foods is based in Copenhagen and is focused on Denmark and broader Nordic expansion.
Why do we include them in the alternative protein market?
Tempty Foods belongs in the alternative protein market because its core products are mycelium-based meat alternatives for human food.
What is the company stage?
Tempty Foods is in early growth, with products already served through channels including 7-Eleven Denmark and Coop.
How much did they raise?
Tempty Foods initially passed €356,538 and later showed €415,439 funded, equal to about $0.48M.
What round is it?
The round was equity crowdfunding.
Why did they raise?
Tempty Foods raised to expand across the Nordics, grow foodservice and retail distribution, and scale an asset-light model.
AuX Labs raised $4M in April 2026
When was it?
The deal was announced on 21 April 2026 and covered by media on 22 April 2026.
Who are they?
AuX Labs uses precision fermentation to produce recombinant casein for cheese that melts, stretches, and cooks like dairy cheese.
Geographical focus?
AuX Labs is based in Toronto and is initially targeting foodservice channels such as pizzerias and cafés.
Why do we include them in the alternative protein market?
AuX Labs belongs in the alternative protein market because it makes animal-free dairy protein for cheese alternatives.
What is the company stage?
AuX Labs is in pre-commercial launch preparation, with GRAS work and customer pilots ahead of wider commercialization.
How much did they raise?
AuX Labs raised $4.0M.
What round is it?
The round was a seed or early funding round.
Why did they raise?
AuX Labs raised to scale production and commercialize animal-free cheese ingredients with better melt, stretch, and cooking performance.
This market map, featured in our alternative protein market deck, highlights top companies and startups in the alternative protein market
Cosaic raised $6M in April 2026
When was it?
The deal was announced on 21 April 2026.
Who are they?
Cosaic makes yeast-derived ingredients that give plant-based and animal-free foods dairy-like creaminess, stability, and functionality.
Geographical focus?
Cosaic is based in Switzerland and works with food and beverage manufacturers globally.
Why do we include them in the alternative protein market?
Cosaic belongs in the alternative protein market because its fermentation-derived ingredient replaces dairy, egg, or additive functionality in alternative foods.
What is the company stage?
Cosaic is in pre-commercial commercialization preparation, with customer trials and launch work underway.
How much did they raise?
Cosaic raised $6.0M.
What round is it?
The round was a seed extension.
Why did they raise?
Cosaic raised to scale Cosaic Neo, advance regulatory and customer development, and help manufacturers replace multiple additives with one ingredient.
Planetary raised about $28M in April 2026
When was it?
The deal was announced on 20 April 2026.
Who are they?
Planetary builds and licenses industrial fermentation infrastructure for food-grade proteins, including mycoprotein and other fermentation-derived ingredients.
Geographical focus?
Planetary is based in Switzerland and is pursuing a global licensing model for fermentation production.
Why do we include them in the alternative protein market?
Planetary belongs in the alternative protein market because it supports fermentation-derived proteins for alternative meat and dairy applications.
What is the company stage?
Planetary is in commercial scale-up, with industrial production in Switzerland and a mycoprotein chicken filet launched in ALDI Suisse.
How much did they raise?
Planetary raised about $28.0M, including about $20M in Series A equity and about $7.5M in credit.
What round is it?
The round was a Series A combined with a credit facility.
Why did they raise?
Planetary raised to expand fermentation infrastructure, commercialize its licensing model, and scale lower-cost production of food-grade proteins.
This chart, featured in our alternative protein market deck, shows annual funding in alternative protein startups
Standing Ovation raised about $34.2M in March 2026
When was it?
The deal was announced on 31 March 2026.
Who are they?
Standing Ovation produces animal-free casein through precision fermentation for cheese, yogurt, and other dairy applications.
Geographical focus?
Standing Ovation is based in France and is preparing for commercialization in North America before expanding to Europe and Asia.
Why do we include them in the alternative protein market?
Standing Ovation belongs in the alternative protein market because it makes animal-free dairy protein that replaces conventional milk casein.
What is the company stage?
Standing Ovation is in commercialization and regulatory scale-up, with North American entry and manufacturing expansion as priorities.
How much did they raise?
Standing Ovation raised €30M, equal to about $34.2M, including €25M equity and €5M non-dilutive financing.
What round is it?
The round was a Series B combined with non-dilutive financing.
Why did they raise?
Standing Ovation raised to commercialize animal-free casein in North America, expand manufacturing capacity, and scale through dairy partnerships.
Those Vegan Cowboys raised about $14.2M in March 2026
When was it?
The combined raise was announced on 6 March 2026 after a record crowdfunding campaign.
Who are they?
Those Vegan Cowboys makes precision-fermented casein for cow-free cheese and other dairy applications.
Geographical focus?
Those Vegan Cowboys is Dutch-Belgian and is preparing a US launch first, with later regulatory filings planned in other markets.
Why do we include them in the alternative protein market?
Those Vegan Cowboys belongs in the alternative protein market because it produces animal-free dairy proteins for cheese.
What is the company stage?
Those Vegan Cowboys is in pre-commercial industrial scale-up, with self-affirmed GRAS status and work with industrial partners.
How much did they raise?
Those Vegan Cowboys raised €12.25M, equal to about $14.2M, across external funding, crowdfunding, and an additional investor.
What round is it?
The round was equity funding combined with equity crowdfunding.
Why did they raise?
Those Vegan Cowboys raised to fine-tune animal-free casein, prepare industrial-scale production, and bring cow-free cheese closer to launch.
Related blog posts
- How strong is fundraising in the alternative protein market right now?
- What is the latest news in the alternative protein market?
- What is the actual size of the alternative protein market?
- How funding activity has evolved in the alternative protein market
- What are the key fundraising trends in the alternative protein market?
- A complete overview of funding deals in alternative proteins
- Which companies have raised the most funding in the alternative protein market?
- Which companies are the most valued in the alternative protein market?
- A complete list of business models in the alternative protein market
